Tissue lectins are emerging (patho)physiological effectors with broad significance. The capacity of adhesion/growth-regulatory galectins to form functional complexes with distinct cellular glycoconjugates is based on molecular selection of matching partners. Engineering of variants by changing the topological display of carbohydrate recognition domains (CRDs) provides tools to understand the inherent specificity of the functional pairing. We here illustrate its practical implementation in the case of human tandem-repeat-type galectin-8 (Gal-8). It is termed Gal-8 (NC) due to presence of two different CRDs at the N- and C-terminal positions. Gal-8N exhibits exceptionally high affinity for 3′-sialylated/sulfated β-galactosides. This protein i...
Galectins (Gals) constitute a family of mammalian lectins with affinity for β-galactosides, characte...
Galectins represent β-galactoside-binding proteins and are known to bind Galβ1-3/ 4GlcNAc disacchari...
Galectin-8 has two different carbohydrate recognition domains (CRDs), the N-terminal Gal-8N and the ...
Tissue lectins are emerging (patho) physiological effectors with broad significance. The capacity of...
Tissue lectins are emerging (patho) physiological effectors with broad significance. The capacity of...
Tissue lectins are emerging (patho) physiological effectors with broad significance. The capacity of...
Tissue lectins are emerging (patho) physiological effectors with broad significance. The capacity of...
Tissue lectins are emerging (patho) physiological effectors with broad significance. The capacity of...
<div><p>Human Galectin-8 (Gal-8) is a member of the galectin family which shares an affinity for β-g...
The concept of biomedical significance of the functional pairing between tissue lectins and their gl...
Abstract Galectins are a protein family with diverse biological functions, which are unique in speci...
Galectins are implicated in a large variety of biological functions, many of which depend on their c...
Galectins represent β-galactoside-binding proteins and are known to bind Galβ1-3/4GlcNAc disaccharid...
Adhesion/growth-regulatory galectins (gals) exert their functionality by the cis/trans-cross-linking...
Galectins are animal lectins with affinity to terminal β-galactosides. These lectins are characteriz...
Galectins (Gals) constitute a family of mammalian lectins with affinity for β-galactosides, characte...
Galectins represent β-galactoside-binding proteins and are known to bind Galβ1-3/ 4GlcNAc disacchari...
Galectin-8 has two different carbohydrate recognition domains (CRDs), the N-terminal Gal-8N and the ...
Tissue lectins are emerging (patho) physiological effectors with broad significance. The capacity of...
Tissue lectins are emerging (patho) physiological effectors with broad significance. The capacity of...
Tissue lectins are emerging (patho) physiological effectors with broad significance. The capacity of...
Tissue lectins are emerging (patho) physiological effectors with broad significance. The capacity of...
Tissue lectins are emerging (patho) physiological effectors with broad significance. The capacity of...
<div><p>Human Galectin-8 (Gal-8) is a member of the galectin family which shares an affinity for β-g...
The concept of biomedical significance of the functional pairing between tissue lectins and their gl...
Abstract Galectins are a protein family with diverse biological functions, which are unique in speci...
Galectins are implicated in a large variety of biological functions, many of which depend on their c...
Galectins represent β-galactoside-binding proteins and are known to bind Galβ1-3/4GlcNAc disaccharid...
Adhesion/growth-regulatory galectins (gals) exert their functionality by the cis/trans-cross-linking...
Galectins are animal lectins with affinity to terminal β-galactosides. These lectins are characteriz...
Galectins (Gals) constitute a family of mammalian lectins with affinity for β-galactosides, characte...
Galectins represent β-galactoside-binding proteins and are known to bind Galβ1-3/ 4GlcNAc disacchari...
Galectin-8 has two different carbohydrate recognition domains (CRDs), the N-terminal Gal-8N and the ...